Embassy Pharmaceutical AND Chemicals Limited Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: Embassy Pharmaceutical AND Chemicals Limited Pharmaceutical Import Records from India — 4 Products, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Embassy Pharmaceutical AND Chemicals Limited — Pharmaceutical Importer Profile (2026) | 4 Products, $1.9M Trade | TransData Nexus

Embassy Pharmaceutical AND Chemicals Limited

Pharmaceutical Importer · Nigeria · Respiratory & OTC Focus · $1.9M Total Trade · DGFT Verified

Embassy Pharmaceutical AND Chemicals Limited is a pharmaceutical importer based in Nigeria with a total trade value of $1.9M across 4 products in 2 therapeutic categories. Based on 45 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Embassy Pharmaceutical AND Chemicals Limited sources from 1 verified Indian supplier, with Laborate Pharmaceutical India Limited accounting for 100.0% of imports.

Embassy Pharmaceutical AND Chemicals Limited — Import Portfolio & Supplier Network

Embassy Pharmaceutical AND Chemicals Limited import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Embassy Pharmaceutical AND Chemicals Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Laborate Pharmaceutical India Limited	$1.8M	79	100.0%

Embassy Pharmaceutical AND Chemicals Limited sources from 1 verified Indian supplier across 74 distinct formulations. The sourcing is highly concentrated — Laborate Pharmaceutical India Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
1-980 kold time tabletparacetamol BP 500MG+caffeine BP 25MG +pseudoephedrine hcl BP 30MG+chlorphenamine maleate BP 2MG	$300.0K	6
1-377 embacef 500 tabletcefuroxime axetil 500mgbatchnos:nebte-001 manufacturing . 09/23 exp. 08/26 16x10x1x1060260packs	$50.0K	1
1-300 quinine INJ. 2mlquinine dihydrochloride 600MG/2ML benzyl alcohol as preservative 2%v/vbatchnos:edqsi-001 to	$50.0K	1
1-1241 ketoral 200 tabletketoconazole USP 200mgbatchnos:kzst-003 manufacturing . 10/23 exp. 09/26 20x10x1x10qty:24820box	$50.0K	1
1-1210 ketoral 200 tabletketoconazole USP 200mgbatchnos:kzst-004 manufacturing . 10/23 exp. 09/26 20x10x1x10qty:24200box	$50.0K	1
1-980 kold time tabletparacetamol BP 500MG+caffeine BP 25MG +pseudoephedrine hcl BP 30MG+ chlorphenamine maleate BP 2MG	$50.0K	1
1-805 troxone injection 1gceftriaxone sodium 1000MG+10ML wfibatchnos:nerie-008& nerie-009 manufacturing . 09/23 exp. 08/26	$49.1K	1
1-1000 labdic relief mr tabletdiclofenac sodium 50MG chlorzoxazone 250MG paracetamol 500mgbatchnos:23lmr-01 to	$48.3K	1
1242-1773 labnat injection 1mlartemether 80MG/ML benzyl alcohol as preservative 1%w/vbatchnos:ealsi-028 to	$48.1K	1
688-1103 labnat injection 1mlartemether80mg/ML benzyl alcohol as preservative 1%w/vbatchnos:ealsi-009 to	$45.3K	1
1-1401 medysten forte cream 20gclotrimazole 1% betamethasone 0.05%neomycin sulfate 0.5%batchnos:23ms48 to 23ms57	$44.1K	1
705-1170 labnat injection 1mlartemether80mg/ML benzyl alcohol as preservative 1%w/vbatchnos:ealsi-023 to	$42.0K	1
1-990 emba ciproxamed tabletciprofloxacin hydrochloride 500mgbatchnos:ecst-052& ecst-053 manufacturing . 09/23 exp. 08/27	$37.2K	1
626-1285 mezol c injectionomeprazole sodium 40mgbatchnos:23oz-02 to 23oz-04 manufacturing . 08/23 exp. 07/26	$35.1K	1
1-380 kaka forte tabletparacetamol 500MG caffeine 30mgbatchnos:nkkte-017 & nkkte-018 manufacturing . 11/23 exp. 10/26	$29.1K	1

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Caffeine	Respiratory & OTC	$600.0K	12	0.6%	16
2	Ephedrine	Respiratory & OTC	$450.0K	9	1.6%	9
3	Pseudoephedrine	Respiratory & OTC	$450.0K	9	2.9%	5
4	Vati	Ayurvedic & Herbal Products	$411.9K	15	1.6%	14

Embassy Pharmaceutical AND Chemicals Limited imports 4 pharmaceutical products across 2 categories into Nigeria totaling $1.9M.

Embassy Pharmaceutical AND Chemicals Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Embassy Pharmaceutical and Chemicals Limited, established in 1986, is a Nigerian pharmaceutical importer and distributor headquartered at 41, Ademola Street, South West Ikoyi, Lagos. (embassypharma.com.ng) The company is registered with the Corporate Affairs Commission under Registration Number RC: 82,878. Embassy Pharma's mission is to become the most valuable company in the pharmaceutical industry by providing the Nigerian population with a wide range of world-class, quality, and efficacious pharmaceutical products at affordable prices. (embassypharma.com.ng)

The company offers an extensive portfolio of over 350 pharmaceutical products registered with the National Agency for Food and Drug Administration and Control (NAFDAC). (embassypharma.com.ng) These products span various therapeutic classes, including antineoplastics, antibacterials, analgesics, anti-inflammatory drugs, antipyretics, and more. (embassypharma.com.ng) In addition to pharmaceuticals, Embassy Pharma markets hospital disposables such as syringes of various capacities, HCG, malaria test kits, and medical/diagnostic equipment like X-ray machines. (embassypharma.com.ng)

2Distribution Network

Embassy Pharmaceutical and Chemicals Limited operates its administrative headquarters and registered office at 41, Ademola Street, South West Ikoyi, Lagos. (embassypharma.com.ng) While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive product portfolio and partnerships suggest a well-established distribution network within Nigeria. Embassy Pharma's partnerships with international suppliers, including Laborate Pharmaceutical India Limited, Medical and Chemical Agency (MCA) S.p.A. from Italy, and Eternal Mark Pvt. Limited from China, indicate a global sourcing strategy. (embassypharma.com.ng)

3Industry Role

Embassy Pharmaceutical and Chemicals Limited functions primarily as a pharmaceutical importer and distributor within Nigeria's pharmaceutical supply chain. By sourcing a diverse range of pharmaceutical products from international suppliers and distributing them across Nigeria, the company plays a crucial role in ensuring the availability of quality medicines and medical supplies to meet the healthcare needs of the Nigerian population. (embassypharma.com.ng)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Embassy Pharmaceutical AND Chemicals Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Embassy Pharmaceutical and Chemicals Limited's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from a single supplier: Laborate Pharmaceutical India Limited. This supplier accounts for $1.8 million of the total import value, representing 79 shipments and 100% of the company's imports from India. (embassypharma.com.ng)

This single-source dependency may pose risks related to supply chain disruptions, such as production delays, quality control issues, or geopolitical factors affecting trade relations. However, the consistent volume of shipments and the substantial financial commitment suggest a stable and strategic partnership between Embassy Pharma and Laborate Pharmaceutical India Limited. The company's focus on a limited number of products—specifically, caffeine, ephedrine, pseudoephedrine, and vati—indicates a targeted approach to meet specific market demands. (embassypharma.com.ng)

2Supply Chain Resilience

Embassy Pharmaceutical and Chemicals Limited's supply chain resilience is closely tied to its reliance on Laborate Pharmaceutical India Limited as the primary supplier for its pharmaceutical imports. The absence of publicly disclosed backup suppliers suggests a potential vulnerability in the event of disruptions affecting Laborate Pharmaceutical's operations. The company's importation of finished pharmaceutical formulations, rather than raw active pharmaceutical ingredients (APIs) or bulk drugs, indicates a focus on ready-to-market products, which may streamline distribution but also limit flexibility in sourcing alternatives. Additionally, the concentration of shipments from a single supplier may expose the company to risks associated with shipping routes and regulatory compliance specific to that supplier. (embassypharma.com.ng)

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) serves as the primary regulatory authority overseeing the importation, manufacture, distribution, and sale of pharmaceutical products. NAFDAC operates under the National Agency for Food and Drug Administration and Control Act Cap N1, Laws of the Federation of Nigeria (LFN), 2004, which provides the legal framework for its operations. (freyrsolutions.com.ng)

The Pharmaceutical Council of Nigeria (PCN) also plays a significant role in regulating the professional practices of pharmacists and ensuring the quality and safety of pharmaceutical services in the country. Both NAFDAC and PCN collaborate to enforce standards and guidelines that govern the pharmaceutical industry in Nigeria. (freyrsolutions.com.ng)

2Import Licensing & GMP

Importers of pharmaceutical products into Nigeria must obtain the necessary licenses and approvals from NAFDAC. This process includes registering the pharmaceutical company with NAFDAC, obtaining a valid import permit, and ensuring that imported products are registered with NAFDAC. The registration process involves submitting applications for product registration, which are valid for five years upon approval.

Regarding Good Manufacturing Practice (GMP) certification, NAFDAC recognizes GMP certificates from reputable international bodies, including the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their suppliers hold valid GMP certifications from recognized authorities to comply with NAFDAC's standards.

Embassy Pharmaceutical AND Chemicals Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Embassy Pharmaceutical and Chemicals Limited's product strategy focuses on importing finished pharmaceutical formulations, particularly in the respiratory and over-the-counter (OTC) categories, which constitute 78.5% of their imports, and Ayurvedic and herbal products, accounting for 21.5%. (embassypharma.com.ng) The top five imported products—caffeine, ephedrine, pseudoephedrine, and vati—align with these therapeutic areas. This focus suggests a strategic response to market demand for treatments in respiratory conditions and a growing interest in alternative medicine options among Nigerian consumers.

2Sourcing Profile

Embassy Pharmaceutical and Chemicals Limited's sourcing strategy emphasizes importing finished pharmaceutical formulations from international suppliers, with a notable concentration on products from India. This approach allows the company to offer a diverse range of products without the complexities associated with manufacturing raw active pharmaceutical ingredients (APIs). The reliance on a single supplier for a significant portion of imports indicates a strategic partnership aimed at ensuring product quality and consistency. (embassypharma.com.ng)

3Market Positioning

Seller's Guide — How to Become a Supplier to Embassy Pharmaceutical AND Chemicals Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Embassy Pharmaceutical and Chemicals Limited, particularly in the therapeutic areas of respiratory and OTC medications, as well as Ayurvedic and herbal products. The company's current sourcing strategy, which heavily relies on a single supplier for a significant portion of imports, presents an opportunity for diversification. Indian exporters can explore this potential by demonstrating the ability to meet NAFDAC's regulatory requirements, offering competitive pricing, and ensuring consistent product quality

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Embassy Pharmaceutical AND Chemicals Limited

What products does Embassy Pharmaceutical AND Chemicals Limited import from India?

Embassy Pharmaceutical AND Chemicals Limited imports 4 pharmaceutical products across 2 categories. Top imports: Caffeine ($600.0K), Ephedrine ($450.0K), Pseudoephedrine ($450.0K), Vati ($411.9K).

Who supplies pharmaceuticals to Embassy Pharmaceutical AND Chemicals Limited from India?

Embassy Pharmaceutical AND Chemicals Limited sources from 1 verified Indian suppliers. The primary supplier is Laborate Pharmaceutical India Limited (100.0% of imports, $1.8M).

What is Embassy Pharmaceutical AND Chemicals Limited's total pharmaceutical import value?

Embassy Pharmaceutical AND Chemicals Limited's total pharmaceutical import value from India is $1.9M, based on 45 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Embassy Pharmaceutical AND Chemicals Limited focus on?

Embassy Pharmaceutical AND Chemicals Limited imports across 2 categories. The largest: Respiratory & OTC (78.5%), Ayurvedic & Herbal Products (21.5%).

Get Full Embassy Pharmaceutical AND Chemicals Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.